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ABSTRACT
Background: The occurrence of systemic infections due to C. albicans has increased especially 
in critically ill patients. In fungal infections, secretory mechanisms are key events for disease 
establishment. Recent findings demonstrate that fungal organisms release many molecular com-
ponents to the extracellular space in extracellular vesicles.
Aims: We develop a method to obtain exosomes from yeast cultures of the Candida albicans. 
Methods: Yeast strains used in this work were C. albicans SC5314, C. parapsilosis (ATCC 
22019) and C. krusei (ATCC 6258). Yeasts were grown at 37.º in liquid YPD medium. The cell 
cultures were centrifuged and the supernatant filtered through sterile nitrocellulose. Filtrates 
were concentrated and centrifuged using an ultracentrifuge. The sediment was analyzed by elec-
tron microscopy of transmission.
Results: The transmission of electron microscopy and nanoparticle tracking analysis confirmed 
the presence of extracellular vesicles (exosomes) of sizes between 100 and 200 nm and the ab-
sence of cellular contaminants. This was ratified by the characterization of proteins performed 
through the western blot technique, where the absence of cell contamination in the preparations 
was assessed.
Conclusions: The method proves to be highly effective due to the homogeneity and purity of the 
obtained microvesicles. The protocol developed in this paper proves to be effective for obtain-
ing exosomes of other Candida species, which will allow future studies to determine its protein 
composition and the role that these vesicles can play.
KEYWORDS: exosomes, extracellular vesicles, Candida albicans, tetraspanins.
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RESUMEN
Contexto: La aparición de infecciones sistémicas por C. albicans ha aumentado sobre todo en 
pacientes graves. En las infecciones fúngicas, los mecanismos de secreción son eventos clave 
para que el establecimiento de la enfermedad. Hallazgos recientes demuestran que los orga-
nismos fúngicos liberan muchos componentes moleculares al espacio extracelular en vesículas 
extracelulares.
Objetivos: Desarrollamos un método para obtener exosomas de cultivos de levadura de Candida 
albicans. 
Métodos: Las cepas de levadura que se usaron en este trabajo son C. albicans SC5314, C. parap-
silosis (ATCC 22019) y C. krusei (ATCC 6258). Las levaduras se cultivaron a 37.º C en un medio 
YPD líquido. Los cultivos de células fueron centrifugados y el sobrenadante, filtrado por medio 
de nitrocelulosa estéril. Los filtrados se concentraron y centrifugaron usando una ultracentrifuga-
dora. El sedimento fue analizado por un microscopio electrónico de transmisión. 
Resultados: La microscopía electrónica de transmisión y el análisis de nanopartículas confirman 
la presencia de vesículas extracelulares (exosomas) de un tamaño entre 100 y 200 nm, así como 
la ausencia de contaminantes celulares. Esto se ratificó mediante la caracterización de proteínas 
obtenidas por medio de la técnica de Western blot, donde se evaluó la ausencia de contaminación 
celular en las preparaciones. 
Conclusiones: El método es altamente eficaz dada la homogeneidad y la pureza de las microve-
sículas obtenidas. El protocolo desarrollado en este artículo demuestra ser efectivo para obtener 
exosomas de otras especies Candida, lo que permitirá que en futuros estudios se determine su 
composición proteica y el papel que estas vesículas pueden desempeñar. 
PALABRAS CLAVE: exosomas, vesículas extracelulares, Candida albicans, tetraspaninas.
INTRODUCTION
Candida albicans, a polymorphic fungus with yeast and mycelia as predominant morphological 
forms, is an opportunistic pathogenic; the increase of immunodeficiency patients of different eti-
ologies has caused a significant rise in the incidence of systemic infection caused by this fungus. 
Although C. albicans is usually found in human microbiome, in healthy individuals C. albicans 
generally remains benign as commensal, although it can occasionally cause a variety of infections, 
ranging from superficial relatively mild infections of skin or mucosa, to potentially deadly systemic 
infections. The occurrence of systemic infections due to C. albicans has increased especially in crit-
ically ill patients as a consequence of increasing immune-deficiencies of different origins, such as 
AIDS, antitumor treatment or therapeutic immune suppression in transplant patients [1-9].
The potential of C. albicans to infect different host niches is sustained by various virulence factors 
such as morphological transition between yeast and hyphal forms, the expression of adhesins and 
invasins on the cell surface, thigmotropism, the formation of biofilms, phenotypic switching and the 
secretion of hydrolytic enzymes (proteases, phospholipases and lipases) [10]. In fungal infections, 
secretory mechanisms are key events for disease establishment [11-13] and virulence of C. albicans 
could be associated with some secretion mechanism. Recent findings show that fungal organisms 
release many molecular components to the extracellular space in extracellular vesicles (EV) [13-16].
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Exosomes were discovered nearly 30 years ago, secreted by most cell types and being considered 
as simple garbage containers to transport non-desired components outside the cell. However, in-
creasing evidence presented these containers as vehicles of information from cell to cell and tissues, 
altering the function and physiology of the receiver, and being implicated in tissue repair, neural 
communication or transfer of virulence factors in pathogenesis [17].
Eukaryotes protein secretion is driven by a signal peptide that directly secreted proteins through 
endoplasmic reticulum and Golgi with a concomitant protein glycosylation. However, the presence 
of non-glycosylated proteins lacking signal peptide outside the cell has remained unknown. Recently, 
lots of evidence demonstrated that cells produce vesicles that traverse the cell surface to release a 
wide range of cellular components into the extracellular space. Yeast cells also produce exosomes like 
vesicles that can play different roles in intercellular communication and are the vehicles for secretion 
of non-signal peptides and proteins [18].
Exosomes could play a role in infection by C. albicans, identify the components involved in the 
process, and it might help elucidate possible therapeutic targets and develop potential vaccines or 
immunotherapy against this infection. In this context, to know the molecules transported by Candida 
exosomes could bring important information about their potential role in Candida spp. infections. 
The main aim of this work was to develop a highly effective method for obtaining exosomes of C. al-
bicans with a high degree of purity and free of cellular contamination and to show the possibility of 
extending the method to other Candida species.
MATERIALS AND METHODS
Strains, media and growth conditions 
Yeast strains used in this work were C. albicans SC5314, C. parapsilosis (ATCC 22019) and 
C. krusei (ATCC 6258). Yeasts were grown at 37 ºC in liquid YPD medium (1 % of yeast extract, 
2 % of peptone, and 2 % of glucose). Three flasks of one liter YPD medium were inoculated with 1 
ml from previous 5 ml pre-culture inoculated with an isolated colony. Cultures were incubated in an 
orbital shaking (150 rpm) at 37 °C for 48 hours.
Obtaining yeast-free supernatant
Three liters of cell cultures were centrifuged at 4000xg for 15 min and supernatant filtered through 
sterile nitrocellulose, 0.45 µm pore size, membrane filters (Sartorius®).
Filtrates were concentrated by two hours of crossflow filtration using a Sartorius Vivaflow® 50R 
with an input stream of 200 to 400 mL/min and a pressure output of 2.5 bar, obtaining a final vol-
ume of 50 mL, which was subjected to a further filtration through pore size of 0.20 µm (Sartorius®) 
membrane sterile filters to ensure sterility and absence of other cellular elements but exosomes in the 
sample.
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Ultracentrifugation 
Concentrated filtered samples were centrifuged at 200000xg for 2 h at 4 °C, using an ultracentri-
fuge Beckman Coulter Optima® MAX. Sediment was suspended in PBS buffer (Phosphate Buffer 
Saline: Na2HPO4 and KH2PO4 0.01 M; 0.138 M NaCl; 0.0027 M KCl) pH 7.4, to a final volume of 1 
mL. Aliquots of 100 µL were taken and kept frozen at -30 °C. One aliquot was processed immediately 
without freezing, adding 400 µL of Karnovsky solution (2.5 % paraformaldehyde and glutaraldehyde 
0.5 % in PBS buffer), and processed by an electron microscopy of transmission.
Obtaining yeast cellular extracts
Yeast cells from 1 mL of YPD liquid culture were collected by centrifugation (8000 xg, 10 min). 
Then they were washed with sterile PBS buffer containing 1 mM of phenylmethylsulfonyl fluoride 
(PMSF), and re-suspended in 0.5 mL PBS-PMSF. After that they were dispensed in 2 mL tubes, the 
same volume of glass beads (425-600 µm of diameter, Sigma®) were added and subjected to four 20 s 
agitation cycles in a FastPrep FP120 cell disruptor. Cell extract was recovered, centrifuged at 8000xg 
for 10 minutes and divided in 100 µL aliquots and stored frozen.
Protein quantification 
Quantification was carried out using the method of Bradford [19] and the reagent provided by 
Bio-Rad®.
Transmission electron microscopy (TEM)
Exosome pellets were fixed with 2.5 % of glutaraldehyde and washed with distilled water. After 
that, Exosomes were post fixed with 2 % of osmium tetroxide and dehydrated in increasing concen-
trations of ethanol. Embedding was performed with LR-White resin at 60 ºC for 24-48 h. Ultrathin 
sections were contrasted with 2 % of uranyl acetate and observed in a JEM 1010 TEM (JEOL) elec-
tron microscope at 60 kV.
Exosomes size determination
The size distribution of exosomes was measured using NanoSight LM10 (Malvern, Worcester-
shire, UK) and analyzed with the Nanoparticles Tracking Analysis software (Malvern) according to 
the manufacturer’s protocol. Before each experiment, the machine was calibrated for nanoparticle 
size and quantity using standardized nanoparticle dilutions provided by the manufacturer.
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Protein gel electrophoresis and Western blot techniques 
SDS-PAGE electrophoresis was performed as described elsewhere [20] in 10 % (w/v) acrylamide 
gels loaded with 20 µg protein. The gels were stained with Coomassie brilliant blue or electro-blotted 
onto polyvinylidene difluoride (PVDF) membrane and immune detected with antibodies anti-Calnex-
in, anti-CD9, anti-CD63, anti-CD81, anti-Enolase, anti-Hsp70 (System Biosciences, with a dilution 
of 1:2500) and anti-candida cell wall (our group). Detection was carried out with peroxidase marked 
goat anti-rabbit antibodies (Sigma-Aldrich, with dilution 1:20000) by the enhanced chemilumines-
cent (ECL) method from Amersham Biosciences, following the manufacturer’s instructions [21,22].
Treatment with Concanavalin A-ferritin
Each sample, with the sediment containing the exosome fraction, was resuspended in a solution 
composed of 0.6 M KCl, 0.5 M NaCl and 2 mM in MnCl2, MgCl2 and CaCl2 (solution A), subse-
quently adding Concanavalin A-ferritin to a final concentration 0.5 mg/mL and incubating for 30 min 
at room temperature. Each sample was washed twice with solution A, using ultracentrifugation at 
200000 xg for 70 min at 4 °C, both times. The sediment obtained was resuspended with PBS buffer 
pH 7.4 and fixed with formaldehyde/glutaraldehyde for inclusion in resins and subsequent processing 
for observation by transmission electron microscopy.
RESULTS AND DISCUSSION
Samples of exosomes obtained from C. albicans SC5314 were subjected to an analysis of determi-
nation of the total protein value, obtaining 0.166 µg/µL.
To check the purity of the sample a fraction of exosomes was processed by transmission electronic 
microscopy. Figure 1(A) shows two exosomes from C. albicans SC5314, in which there are vesicu-
lar structures with characteristic double membrane, sizes ranging from 100 to 200 nm. Figure 1(B) 
shows a preparation of exosomes not filtered through a 0.20 μm pore size, membrane filters, in which 
one can see exosome structures mixed with some yeast cells.
The images obtained by transmission electron microscopy have allowed us to validate the method 
of obtaining exosomes, ratifying the purity of the preparations with double membrane extracellular 
vesicles with sizes between 100 and 200 nm. Similar results were obtained with yeast cultures of C. 
krusei and C. parapsilosis, which proves the validity of this method to obtain samples of purified 
microvesicles without cellular contamination (figures 1C and 1D).
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Fig. 1. Images obtained by transmission electron microscopy: (A) Extracellular vesicles of C. albicans SC5314  
purified. (B) Exosomes together with yeasts in samples not filtered by 0.20 μm. (C) Extracellular vesicles of C. krusei 
and C. parapsilosis (D). (E) Purified exosomes of C. albicans SC5314 without treatment with Concanavalin A-ferritin.
C. albicans SC5314 exosomes’ size and purity were evaluated in a Nano Team Sight®, by NTA. 
This technique allows us to determine the size and distribution of particles. The results highlight the 
high homogeneity of particle sizes. The highest concentrations of particles were those corresponding 
to the sizes of 125 nm and 165 nm, 146.1 nm being their average size. A presence of particles with 
size of 245 and 385 nm was observed, but they were not taken into account due to their low number. 
These results corroborate the efficacy of the method to obtain exosomes of high purity.
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Exosome purity was evaluated by Western Blot (WB), using antibody against extracellular vesi-
cles and markers of cytosolic fraction. Figure 2(A) shows the presence of vesicle markers CD9, CD63 
and CD81 antigens epitopes in the fractions of exosomes, while reaction is negative in their respec-
tive cell lysates (L); on the other hand, cytoplasm marker calnexin was only detected in cell lysate. 
Moonlighting proteins were also identified in microvesicles, as one can see in Figure 2(B), enolase 
was only detected in microvesicles, while HSP70 was detected in both microvesicles and supernatant 
(SN) of the last ultracentifugation.
Fig. 2. Results corresponding to the Western blot performed in samples of exosomes of C. albicans using:  
A) Anti-Calnexin, anti-CD63, anti-CD9 and anti-CD81 antibodies in samples of EV and their corresponding (L).  
B) Anti-enolase, and anti-Hsp70 antibodies in samples of EV and their corresponding SN. C) Positive result with high 
polydispersity of the EV fraction versus the anti-Candida cell wall antibodies.
Tetraspanins such as CD9, CD63 and CD81, are considered to be biomarkers of extracellular ves-
icles by several authors [23-26]. The positive result in the EV fraction and their absence in the cell 
lysate ensures the purity of the obtained exosomes and the absence of cellular contaminants. Calnex-
in (a protein located in the endoplasmic reticulum) is not detected in EV sample, while it is clearly 
present in cell lysate fractions. This allows ratifying the results obtained with tetraspanins about the 
purity of the obtained exosomes and the absence of possible contamination with cellular fragments.
Purified exosomes were also tested for presence of mannoproteins; in order to achieve this we treat-
ed exosomes samples with Concanavalin A-ferritin. Transmission electron microscope images show 
black dotted spots inside the vesicles (Fig 1E), not observed in not treated samples (figure 1A), which 
indicates the presence of mannoproteins in the microvesicles and confirms the results obtained by WB 
of microvesicles proteins detected with anti-mannan (anti-Candida cell wall) antibodies (figure 2C). 
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The method developed introduces modifications to previous protocols to purify yeast microvesi-
cles/exosomes which are free of pollution cytoplasmic contamination that might interfere with fol-
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